At close: December 13 at 4:00:00 PM EST
After hours: 7:16:32 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
12,399.0000
4,681.0000
3,860.0000
Operating Income
-12,399.0000
-4,681.0000
-3,860.0000
Net Non Operating Interest Income Expense
-4,739.0000
144.0000
29.0000
Other Income Expense
701.0000
-539.0000
367.0000
Pretax Income
-16,437.0000
-5,076.0000
-3,464.0000
Tax Provision
15.0000
32.0000
24.0000
Net Income Common Stockholders
-16,424.0000
-4,942.0000
-3,215.0000
Diluted NI Available to Com Stockholders
-16,424.0000
-4,942.0000
-3,215.0000
Basic EPS
-1.47
-0.61
-0.39
Diluted EPS
-1.47
-0.61
-0.39
Basic Average Shares
11,180.0310
8,151.6500
8,151.6500
Diluted Average Shares
11,180.0310
8,151.6500
8,151.6500
Total Operating Income as Reported
-12,399.0000
-4,681.0000
-3,860.0000
Rent Expense Supplemental
109.0000
86.0000
71.0000
Total Expenses
12,399.0000
4,681.0000
3,860.0000
Net Income from Continuing & Discontinued Operation
-16,424.0000
-4,942.0000
-3,215.0000
Normalized Income
-16,963.7700
-4,526.9700
-3,497.5900
Interest Income
58.0000
153.0000
114.0000
Net Interest Income
-4,739.0000
144.0000
29.0000
EBIT
-12,399.0000
-4,681.0000
-3,860.0000
EBITDA
-12,356.0000
-4,636.0000
-3,803.0000
Reconciled Depreciation
43.0000
45.0000
57.0000
Net Income from Continuing Operation Net Minority Interest
-16,424.0000
-4,942.0000
-3,215.0000
Total Unusual Items Excluding Goodwill
701.0000
-539.0000
367.0000
Total Unusual Items
701.0000
-539.0000
367.0000
Normalized EBITDA
-13,057.0000
-4,097.0000
-4,170.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
161.2300
-123.9700
84.4100
12/31/2022 - 4/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
PALI Palisade Bio, Inc.
1.7700
-25.00%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
TRVI Trevi Therapeutics, Inc.
4.1700
+15.83%
IPHA Innate Pharma S.A.
3.0200
+96.10%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
CMRX Chimerix, Inc.
2.9500
+0.34%
DBVT DBV Technologies S.A.
3.5700
-7.03%